Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Fertil Steril. 2021 Mar 19;116(1):208–217. doi: 10.1016/j.fertnstert.2021.02.007

Table 2:

Multivariable Adjusted Associations of AMH with Hormonal Contraceptive Usea, Cumulative Duration of Use, Age at Start, and Time Since Last Use Compared to Never Usersb

N Estimate of % change in AMH (95% CI)
Status of hormonal contraceptive use
Never 232 Reference
Former 951 −4.4% (−16.3%, 9.0%)
Current 460 −25.2% (−35.3%, −13.6%)
Total duration of hormonal contraceptive use (ever users)
Current and cumulative use <1 year 20 −33.5% (−56.1%, 0.8%)
Current and cumulative use 1–3 years 92 −21.1% (−36.9%, −1.4%)
Current and cumulative use ≥4 years 328 −26.9% (−37.4%, −14.7%)
Former and cumulative use <1 year 183 −2.2% (−18.1%, 16.8%)
Former and cumulative use 1–3 years 354 −3.4% (−17.0%, 12.5%)
Former and cumulative use ≥4 years 414 −6.5% (−19.5%, 8.6%)
Age at start of hormonal contraceptive (ever users)
<15 years 145 −12.2% (−27.5%, 6.3%)
15–20 years 968 −11.3% (−22.3%, 1.3%)
21–25 years 236 −14.0% (−27.3%, 1.6%)
≥26 years 47 −19.7% (−39.9%, 7.2%)
Time since last use of hormonal contraceptive (ever users)
Current 460 −26.1% (−36.2%, −14.5%)
Within last year 124 −5.1% (−22.2%, 15.8%)
> 1 year ago 827 −4.4% (−16.4%, 9.4%)
a

Includes users of COC, ring, DMPA, implant, patch and LNG-IUD

b

The reference group is “never users” (n= 232)

The multivariable model adjusted for age, age2, BMI, and reported histories of PCOS, abnormal menstrual bleeding, thyroid condition, and seeking care for difficulty conceiving.